biotech firesales Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech firesales

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LJM who wrote (1083)	7/28/2006 10:08:43 AM
From: tuck	Read Replies (2) of 3661

GTOP off 42% after DSMB recommends their MyVax trial in fNHL continue, with a second interim look. >>REDWOOD CITY, Calif., July 27 /PRNewswire-FirstCall/ -- Genitope Corporation (Nasdaq: GTOP - News) today announced that its independent Data Safety Monitoring Board (DSMB) reviewed the second planned interim analysis of data for efficacy in its pivotal Phase 3 clinical trial for treatment of follicular non-Hodgkin's Lymphoma (fNHL) and recommended that the trial continue as planned. The clinical trial will be completed by December 2007. This trial evaluates the safety and efficacy of the company's lead product candidate, MyVax® personalized immunotherapy, in patients with previously untreated fNHL. The trial compares patients treated with MyVax® personalized immunotherapy to patients treated with a nonspecific immunotherapy control. The company will hold a conference call Friday, July 28, 2006 at 9:00 AM EDT. The dial-in number for U.S. and Canada is 866-770-7146 (passcode 93670350). The international dial-in is 617-213-8068 (passcode 93670350). The call can also be accessed in a listen-only mode on Genitope Corporation's Web site at www.genitope.com . The Web cast will be archived for 30 days.<< Not sure what the problem is here, as I don't follow the company. Perhaps the trial was expected to finish sooner? Edit: Believe there was hope that the trial could be stopped for efficacy if p value was less than .002. That's a tough one to hit, and apparently GTOP didn't do it. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next